PetVivo (PETV) Stock Price, News & Analysis

Company Overview

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Key Stats

• Today's Range: $0.54 to $0.58
• 50-Day Range: $0.40 to $0.58
• 52-Week Range: $0.29 to $1.50
• Volume: 33,622 shs
• Average Volume: 33,468 shs
• Market Capitalization: $11.93 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PETV Stock Analysis - Frequently Asked Questions

How have PETV shares performed this year?

PetVivo's stock was trading at $1.06 at the beginning of 2024. Since then, PETV stock has decreased by 45.3% and is now trading at $0.5799.
View the best growth stocks for 2024 here.

How were PetVivo's earnings last quarter?

PetVivo Holdings, Inc. (NASDAQ:PETV) released its earnings results on Thursday, June, 29th. The company reported ($0.21) earnings per share for the quarter, meeting the consensus estimate of ($0.21). The firm had revenue of $0.13 million for the quarter. PetVivo had a negative net margin of 889.99% and a negative trailing twelve-month return on equity of 1,213.96%.

How do I buy shares of PetVivo?

Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of PetVivo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PetVivo investors own include HubSpot (HUBS), Domino's Pizza (DPZ), ForgeRock (FORG), Netflix (NFLX), Sportradar Group (SRAD), Dutch Bros (BROS) and ConocoPhillips (COP).

Company Calendar

• Last Earnings: 6/29/2023
• Today: 12/27/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:PETV
• CUSIP: N/A
• CIK: 1512922
• Web: www.petvivo.com
• Phone: 952-405-6216
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.48)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-10,950,000.00
• Net Margins: -889.99%
• Pretax Margin: N/A
• Return on Equity: -1,213.96%
• Return on Assets: -266.53%

Debt

• Debt-to-Equity Ratio: 0.02
• Current Ratio: 0.67
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: $1.05 million
• Price / Sales: 11.41
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.07 per share
• Price / Book: 8.28

Miscellaneous

• Outstanding Shares: 20,575,000
• Free Float: 16,439,000
• Market Cap: $11.93 million
• Optionable: Not Optionable
• Beta: 2.42